Turtle Creek Wealth Advisors LLC purchased a new stake in Synopsys, Inc. (NASDAQ:SNPS - Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 1,054 shares of the semiconductor company's stock, valued at approximately $540,000.
Other hedge funds have also made changes to their positions in the company. Cornerstone Planning Group LLC increased its position in shares of Synopsys by 275.0% in the first quarter. Cornerstone Planning Group LLC now owns 60 shares of the semiconductor company's stock valued at $25,000 after buying an additional 44 shares in the last quarter. Saudi Central Bank purchased a new stake in Synopsys during the 1st quarter worth about $26,000. Clal Insurance Enterprises Holdings Ltd increased its position in Synopsys by 441.7% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 65 shares of the semiconductor company's stock worth $28,000 after purchasing an additional 53 shares in the last quarter. Independence Bank of Kentucky increased its position in Synopsys by 120.0% during the 2nd quarter. Independence Bank of Kentucky now owns 55 shares of the semiconductor company's stock worth $28,000 after purchasing an additional 30 shares in the last quarter. Finally, WPG Advisers LLC purchased a new stake in Synopsys during the 1st quarter worth about $34,000. Hedge funds and other institutional investors own 85.47% of the company's stock.
Analyst Upgrades and Downgrades
A number of analysts recently commented on the company. JPMorgan Chase & Co. dropped their price objective on Synopsys from $685.00 to $600.00 and set an "overweight" rating for the company in a research report on Wednesday, September 10th. Weiss Ratings reiterated a "hold (c)" rating on shares of Synopsys in a research report on Wednesday, October 8th. Robert W. Baird reiterated a "neutral" rating and set a $535.00 price objective (down previously from $670.00) on shares of Synopsys in a research report on Wednesday, September 10th. Morgan Stanley dropped their price objective on Synopsys from $715.00 to $510.00 and set an "overweight" rating for the company in a research report on Thursday, September 11th. Finally, Wall Street Zen cut Synopsys from a "hold" rating to a "sell" rating in a research report on Saturday, September 13th. Ten investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and four have given a Sell rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Hold" and a consensus target price of $569.67.
Read Our Latest Stock Analysis on Synopsys
Synopsys Stock Up 1.0%
Shares of NASDAQ:SNPS opened at $440.20 on Friday. The stock's 50-day moving average price is $529.15 and its two-hundred day moving average price is $510.15. The company has a current ratio of 1.62, a quick ratio of 1.51 and a debt-to-equity ratio of 0.52. Synopsys, Inc. has a 12-month low of $365.74 and a 12-month high of $651.73. The firm has a market cap of $81.77 billion, a price-to-earnings ratio of 34.55, a PEG ratio of 4.80 and a beta of 1.10.
Synopsys (NASDAQ:SNPS - Get Free Report) last released its quarterly earnings data on Tuesday, September 9th. The semiconductor company reported $2.30 earnings per share for the quarter, missing the consensus estimate of $3.75 by ($1.45). The firm had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.77 billion. Synopsys had a net margin of 31.04% and a return on equity of 10.82%. The business's revenue for the quarter was up 14.0% on a year-over-year basis. During the same period in the prior year, the firm earned $3.43 earnings per share. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. On average, research analysts forecast that Synopsys, Inc. will post 10.64 EPS for the current year.
Insider Transactions at Synopsys
In other news, Director Robert G. Painter acquired 350 shares of Synopsys stock in a transaction dated Thursday, September 11th. The shares were acquired at an average cost of $425.44 per share, with a total value of $148,904.00. Following the purchase, the director directly owned 2,291 shares of the company's stock, valued at approximately $974,683.04. This trade represents a 18.03% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Sassine Ghazi sold 11,366 shares of the business's stock in a transaction that occurred on Tuesday, September 2nd. The stock was sold at an average price of $589.01, for a total value of $6,694,687.66. Following the transaction, the chief executive officer directly owned 71,615 shares in the company, valued at $42,181,951.15. This trade represents a 13.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 30,894 shares of company stock valued at $16,760,783. 0.62% of the stock is currently owned by company insiders.
Synopsys Profile
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.